Hjem › HIV › California › San Francisco
Kliniske studier for HIV i San Francisco, CA
15 studier for HIV søker deltakere på steder i og rundt San Francisco (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- Bridge HIV CRS, San Francisco
SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
RekruttererObservasjonsstudie
- San Francisco General Hospital, San Francisco
Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
RekruttererFase 3
- Optimus Medical Group, San Francisco
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
RekruttererFase 2
- University of California, San Francisco, San Francisco
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Rekrutterer
- University of California, San Francisco, San Francisco
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RekruttererObservasjonsstudie
- University of California, San Francisco, San Francisco
Menopausal HT for Women Living With HIV (HoT)
RekruttererFase 4
- 801 University of California, San Francisco HIV/AIDS CRS, San Francisco
CAR-T Cells for HIV Infection
RekruttererFase 1/2
- Zuckerberg San Francisco General, San Francisco
SCOPE Analytic Treatment Interruption Protocol
Rekrutterer
- University of California San Francisco, San Francisco
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
RekruttererFase 2
- San Francisco General Hospital, San Francisco
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
- Bridge HIV, San Francisco Department of Public Health, San Francisco
Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
RekruttererObservasjonsstudie
- University of California, San Francisco, San Francisco
Text Education About Cardiovascular Health and HIV (TEACH-HIV)
Rekrutterer
- Zuckerberg San Francisco General Hospital, San Francisco
- University of California San Francisco, San Francisco
Imaging Immune Activation in HIV by PET-MR
RekruttererFase 2
- University of California, San Francisco, San Francisco
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
RekruttererFrivillige helsepersonell ønskes velkommen
- San Francisco AIDS Foundation, San Francisco
HIV-studier i andre byer
- Washington, DC22 studier
- New York City, NY19 studier
- Houston, TX17 studier
- Miami, FL17 studier
- Baltimore, MD16 studier
- Atlanta, GA14 studier
- Chicago, IL14 studier
- Boston, MA11 studier
- Philadelphia, PA11 studier
- San Diego, CA10 studier
- Los Angeles, CA9 studier
- Seattle, WA8 studier
Andre studier i San Francisco
- Prostatakreft45 studier
- Brystkreft43 studier
- Ikke-småcellet lungekreft36 studier
- Kreft (alle typer)35 studier
- Hjertesvikt29 studier
- Metastatisk kreft28 studier
- Lungekreft23 studier
- Melanom22 studier
- Pankreaskreft20 studier
- Eggstokkreft19 studier
- Kolorektal kreft18 studier
- Kardiovaskulær sykdom18 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.